Contracts Finder · Award
PHE -ICT- i2 Visual Analysis Tool software Implementation (Covid-19) ecm-7612
A public procurement published by Public Health England via Contracts Finder.
- £37.2k
- Award value
- £37.2k
- Tender value
- 1
- Suppliers
- 1
- Awards
- 1
- Notices
- Award
- Stage
Overview
Implementation of IBM i2 software
Key details
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 48611000 — Database software package
- Currency
- GBP
- Total award value
- £37,185
- Tender value
- £37,185
- First published
- 29 Jan 2021
- Last updated
- 29 Jan 2021
Awards
1 award recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| IBM LIMITED | 01503908 | 10 Sept 2020 | active | £37.2k |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from Public Health England
FAQs about this procurement
Who is the buyer for "PHE -ICT- i2 Visual Analysis Tool software Implementation (Covid-19) ecm-7612"?
PHE -ICT- i2 Visual Analysis Tool software Implementation (Covid-19) ecm-7612 is a UK public-sector procurement published by Public Health England via Contracts Finder.
Has "PHE -ICT- i2 Visual Analysis Tool software Implementation (Covid-19) ecm-7612" been awarded?
Yes — 1 award is recorded, with a reported total value of £37,185. The current lifecycle stage is "Award".
Which suppliers are involved in "PHE -ICT- i2 Visual Analysis Tool software Implementation (Covid-19) ecm-7612"?
1 supplier is linked: IBM LIMITED.
What is "PHE -ICT- i2 Visual Analysis Tool software Implementation (Covid-19) ecm-7612" worth?
The reported award value is £37,185.
When was "PHE -ICT- i2 Visual Analysis Tool software Implementation (Covid-19) ecm-7612" published?
It was first published on 29 Jan 2021 and last updated on 29 Jan 2021, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable